941 Shares in Danaher Co. (NYSE:DHR) Acquired by LVW Advisors LLC

LVW Advisors LLC purchased a new position in shares of Danaher Co. (NYSE:DHR) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 941 shares of the conglomerate’s stock, valued at approximately $235,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of DHR. Cape Investment Advisory Inc. purchased a new position in Danaher during the 4th quarter worth $25,000. Tsfg LLC boosted its position in shares of Danaher by 733.3% in the 1st quarter. Tsfg LLC now owns 100 shares of the conglomerate’s stock worth $25,000 after purchasing an additional 88 shares in the last quarter. BKM Wealth Management LLC acquired a new stake in shares of Danaher in the 4th quarter worth $27,000. Wetzel Investment Advisors Inc. acquired a new stake in shares of Danaher in the 4th quarter worth $29,000. Finally, Rakuten Securities Inc. acquired a new stake in shares of Danaher in the 4th quarter worth $36,000. 79.05% of the stock is owned by institutional investors.

Insider Activity at Danaher

In related news, CEO Rainer Blair sold 9,005 shares of the stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $265.00, for a total value of $2,386,325.00. Following the transaction, the chief executive officer now owns 106,990 shares of the company’s stock, valued at $28,352,350. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In related news, Director Alan G. Spoon sold 708 shares of the firm’s stock in a transaction dated Thursday, May 2nd. The shares were sold at an average price of $243.58, for a total value of $172,454.64. Following the completion of the sale, the director now owns 116,202 shares in the company, valued at $28,304,483.16. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Rainer Blair sold 9,005 shares of the firm’s stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $265.00, for a total transaction of $2,386,325.00. Following the completion of the sale, the chief executive officer now owns 106,990 shares of the company’s stock, valued at approximately $28,352,350. The disclosure for this sale can be found here. Insiders have sold 148,783 shares of company stock valued at $37,536,717 over the last quarter. 10.90% of the stock is owned by insiders.

Danaher Stock Down 0.8 %

Danaher stock opened at $249.85 on Monday. Danaher Co. has a twelve month low of $182.09 and a twelve month high of $269.11. The stock’s fifty day simple moving average is $255.96 and its 200-day simple moving average is $246.75. The company has a current ratio of 1.85, a quick ratio of 1.51 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $185.06 billion, a P/E ratio of 42.35, a P/E/G ratio of 3.82 and a beta of 0.84.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share for the quarter, topping analysts’ consensus estimates of $1.72 by $0.20. Danaher had a return on equity of 11.43% and a net margin of 16.78%. The business had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.62 billion. During the same quarter in the prior year, the company earned $2.36 earnings per share. The company’s revenue was down 2.6% on a year-over-year basis. As a group, equities analysts expect that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be issued a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 0.43%. The ex-dividend date is Friday, June 28th. Danaher’s dividend payout ratio (DPR) is presently 18.31%.

Analysts Set New Price Targets

Several equities analysts recently weighed in on DHR shares. Jefferies Financial Group started coverage on Danaher in a research note on Monday, June 3rd. They issued a “buy” rating and a $295.00 price target for the company. HSBC upgraded Danaher from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $250.00 to $280.00 in a research note on Wednesday, April 17th. TD Cowen boosted their price objective on Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a research note on Wednesday, April 24th. Bank of America boosted their price objective on Danaher from $258.00 to $270.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 24th. Finally, Citigroup boosted their price objective on Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a research note on Wednesday, April 24th. Six investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company. Based on data from MarketBeat, Danaher presently has an average rating of “Moderate Buy” and an average target price of $269.29.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.